Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
Purity
95%
Bosutinib is an antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. Compared to other tyrosine kinase inhibitors, it has a more favourable hematologic toxicity profile.
Properties
Name
Deuterated Bosutinib
Smiles
[2H]C([2H])([2H])N1CCN(C([2H])([2H])CCOC=2C=C3N=CC(C#N)=C(NC=4C=C(OC)C(Cl)=CC4Cl)C3=CC2OC)CC1
Targets
Please log in to see this information
SDS
No records
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$160
2 mg
$240
5 mg
$480
10 mg
$832
15 mg
$1008
20 mg
$1184
25 mg
$1440
30 mg
$1696
35 mg
$1952
40 mg
$2208
45 mg
$2368
50 mg
$2528
75 mg
$3360
100 mg
$POA
Quantity
1
Total amount
$ 480
No records
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:380843-75-4
0
CAS:2733145-45-2
0